Medicaid pays for one-third of drug abuse hospitalizations

NewsGuard 100/100 Score

Medicaid paid for more than one-third of the 1.3 million hospital stays related to prescription or illegal drug abuse in 2005, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

These admissions, for which drug abuse was listed as the primary or secondary cause of hospitalization, cost nearly $10 billion.

About 17 percent of those hospitalized for drug abuse were uninsured, according to the AHRQ analysis. Although in many cases patients abused more than one drug, cocaine accounted for the largest number of stays (457,000), followed by opioids, including both heroin and prescription opiate-based pain relief drugs, such as oxycodone and hydrocodone (339,000). Other drugs that resulted in hospitalizations included marijuana (275,000) and amphetamines, including methamphetamine and prescription stimulants (99,000).

This AHRQ News & Numbers summary is based on data in Hospitalizations Related to Drug Abuse, 2005. The report uses statistics from the Nationwide Inpatient Sample, a database of hospital inpatient stays that is nationally representative of inpatient stays in all short-term, non-federal hospitals. The data are drawn from hospitals that comprise 90 percent of all discharges in the United States and include all patients, regardless of insurance type, as well as the uninsured.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses